Search Results 11-20 of 16992 for intestinal metaplasia
This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...
... intestinal metaplasia following endoscopic ablation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
... metaplasia, dysplasia, or EAC versus patients who ... bowel and colon in subjects with known CD and mucosal disease. ... A Study to Compare COVID-19 Nasal Testing ...
... intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's ...
Recurrence of intestinal metaplasia and dysplasia after complete endoscopic eradication therapy (EET) of dysplasia or early adenocarcinoma is well documented.
Histology showing evidence of intestinal metaplasia with or without presence of dysplasia. ... Patients with a history of esophageal or gastric resection for ...
... intestinal metaplasia. BE , which can progress to dysplasia, is a known risk factor for esophageal adenocarcinoma. A handful of older, smaller studies ...
"Our results suggest the existence of an alternative pathway — one in which metaplasia progresses rapidly to EAC , with or without intestinal metaplasia," says ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.